Contact HIV/AIDS
Info on HIV/AIDS:
206-205-7837
TTY: 206-296-4843
Toll-free: 800-678-1595
Administration:
206-296-4649
HIV/STD Testing
HIV/STD Hotline:
206-205-7837 or
Toll-free: 800-678-1595
11:00 am to 4:00 pm
Monday - Friday for
testing information, resources and referrals
|
|
HIV/AIDS Program
Bibliographies for May - June 2004
| 1. |
Urbina A and Jones K. Crystal Methamphetamine, Its Analogues, and HIV Infection: Medical and Psychiatric Aspects of a New Epidemic. Clinical Infectious Diseases, Mar 15, 2004; 38:890-894.
|
| 2. |
Metsch LR, McCoy CB, Miles CC and Wohler B. Prevention Myths and HIV Risk Reduction by Active Drugs Users. AIDS Education and Prevention, 2004; 16(2): 150-159.
|
| 3. |
Wood E, Spittal PM, Small W et al. Displacement of Canada’s Largest Public Illicit Drug Market in Reponse to a Police Crackdown. Canadian Medical Association Journal, May 11, 2004; 170(10): 1551-1556.
|
| 4. |
Battegay M, Bucher HC and Vernazza P. Sexual Risk Behavior in HIV-Infected Injection Drug Users. Clinical Infectious Diseases, April 15, 2004; 38:1175-1177.
|
| 5. |
Ksobiech K. Assessing and Improving Needle Exchange Programs: Gaps and Problems in the Literature. Harm Reduction Journal, 2004; I:4. On-line at: www.harmreductionjournal.com/content/1/1/4.
|
| 6. |
Ksobiech K. Return Rates for Needle Exchange Programs: A Common Criticism Answered. Harm Reduction Journal, 2004; 1:2. On-line at: www.harmreductionjournal.com/content/1/1/2.
|
| 7. |
Wood E, Spittal P, Li K et al. Inability to Access Addiction Treatment and Risk of HIV Infection Among Injection Drug Users. JAIDS, June 1, 2004; 36(2): 750-754.
|
| 8. |
Perlis TE, Des Jarlais D, Friedman SR et al. Audio-computerized Self-Interviewing Versus Face-to-Face Interviewing for Research Data Collection at Drug Abuse Treatment Programs. Addiction, 2004; 99: 885-896.
|
| 9. |
Ksobiech K. Assessing and Improving Needle Exchange Programs: Gaps and Problems in the Literature. Harm Reduction Journal, 2004; 1: 7 pages. Available on-line at: www.harmreductionjournal.com/content/1/1/4.
|
| 10. |
Tommasello AC. Substance Abuse and Pharmacy Practice: What the Community Pharmacist Needs to Know About Drug Abuse and Dependence. Harm Reduction Journal, 2004; 1: 15 pages. On-line at: www.harmreductionjournal.com/content/1/1/3.
|
| 11. |
Stancliff S. Buprenorphine and the Treatment of Opioid Addiction. PRN Notebook, March, 2004; 9(1): 28-32. On-line at: www.prn.org.
|
| 12. |
Seal DW and Ehrhardt AA. HIV- Prevention-Related Sexual Health Promotion for Heterosexual Men in the United States: Pitfalls and Recommendations. Archives of Sexual Behavior, June 2004: 33(3): 211-222.
|
| 13. |
Holmes KK, Levine R and Weaver M. Effectiveness of Condoms in Preventing Sexually Transmitted Infections. Bulletin of WHO, June 2004; 82(6): 454-461. On-line at: http://www.who.int/bulletin/volumes/82/6/en/.
|
| 14. |
Wong ML, Chan R and Koh D. Long-Term Effects of Condom Promotion Programmes for Vaginal and Oral Sex on Sexually Transmitted Infections among Sex Workers in Singapore. AIDS, 2004; 18(8): 1195-1199.
|
| 15. |
Richardson JL, Milam J, McCutchan A et al. Effect of Brief Safer-Sex Counseling by Medical Providers to HIV-1 Seropositive Patients: A Multi-Clinic Assessment. AIDS, 2004; 18(8): 1179-1186.
|
| 16. |
Coyle KK, Kirby DB, Marin BV et al. Draw the Line/Respect the Line: A Randomized Trial of a Middle School Intervention to Reduce Sexual Risk Behaviors. American Journal Public Health, May 2004; 94(5): 843-851.
|
| 17. |
Stockman JK, Schwarcz SK, Butler,LR et al. HIV Prevention Fatigue Among High-Risk Populations in San Francisco. J Acquir Immune Defic Syndr, April 1, 2004; 35(4): 432-434.
|
| 18. |
Martin JN, Roland ME, Neilands TB et al. Use of Postexposure Prophylaxis Against HIV Infection Following Sexual Exposure Does Not Lead to Increases in High-Risk Behavior. AIDS, 2004; 18(5): 787-792.
|
Men Who Have Sex With Men (MSM)
|
| 19. |
Relf MV, Huang B, Campbell JC et al. Gay Identify, Interpersonal Violence, and HIV Risk Behaviors: An Empirical Test of Theoretical Relationships Among a Probability-Based Sample of Urban Men Who Have Sex With Men. Journal of The Association of Nurses in AIDS Care, March/April 2004; 14-26.
|
| 20. |
Golden MR, Brewer DD, Kurth A et al. Importance of Sex Partner HIV Status in HIV Risk Assessment Among Men Who Have Sex With Men. JAIDS, June 1, 2004; 36(2): 734-742.
|
| 21. |
Myers T, Aguinaldo JP, Dakers D et al. How Drug Using Men Who Have Sex With Men Account for Substance Use During Sexual Behaviors: Questioning Assumptions of HIV Prevention and Research. Addiction Res & Theory, June 2004; 12(3): 213-229.
|
| 22. |
Gullette DL and Turner JG. Stages of Change and Condom Use Among an Internet Sample of Gay and Bisexual Men. Journal of the Association of Nurses in AIDS Care, March/April 2004; 27-37.
|
| 23. |
CDC. Increases in Fluoroquinolone-Resistant Neisseria Gonorrhoeae Among Men Who Have Sex With Men -- United States, 2003, and Revised Recommendations for Gonorrhea Treatment, 2004. MMWR, April 30, 2004; 53(16): 335-338.
|
| 24. |
Catoldo M and Wrightson B. Cultural Competence and HIV. HIV Counselor Perspectives, April 2004; 13(2): 1-8.
|
| 25. |
Hopcke RH. The Place of Religion and Spirituality in HIV Counseling. FOCUS, May 2004; 19(5): 1-8.
|
| 26. |
Wood E, Hogg RS, Yip B et al. The Impact of Adherence on CD4 Cell Count Responses Among HIV-Infected Patients. J Acquir Immune Defic Syndr, March 1, 2004; 35(3): 261-268.
|
| 27. |
Furler MD, Einarson,TR, Millson M et al. Medicinal and Recreational Marijuana Use by Patients Infected With HIV. AIDS Patient Care and STDs, 2004; 18(4): 215-228.
|
| 28. |
Morrism A, Kingsley LA, Groner G et al. Prevalence and Clinical Predictors of Pneumocystis Colonization Among HIV-Infected Men. AIDS, 2004; 18(5): 793-798.
|
| 29. |
Ciasullo EC. Working Positive: Returning to Life. GMHC Treatment Issues, Mar/April 2004; 18(3/4): 1-16. On-line at: http://www.gmhc.org/health/treatment/ti/ti1803.html.
|
| 30. |
Palefsky J. Diagnosis and Management of HPV-Associated Anogenital Dysplasia in HIV-Infected Men and Women. PRN Notebook, June, 2004; 9(2): 24-31. On-line at: www.prn.org.
|
Sexually Transmitted Diseases
|
| 31. |
Wolday D, Gebremariam Z, Mohammed Z et al. The Impact of Syndromic Treatment of Sexually Transmitted Diseases on Genital Shedding of HIV-1. AIDS, 2004; 18(5): 781-785.
|
| 32. |
Miller WC, Ford CA, Morris M et al. Prevalence of Chlamydial and Gonococcal Infections Among Young Adults in the United States. JAMA, May 12, 2004; 291(18): 2229-2236.
|
| 33. |
Kimberlin DW and Rouse DJ. Genital Herpes. The New England Journal of Medicine. May 6, 2004; 350:1970-1977.
|
| 34. |
Celum C, Levine R, Weaver M and Wald A. Genital Herpes and HIV: Double Trouble. Bull WHO, June 2004; 82(6): 447-453. On-line at: http://www.who.int/bulletin/volumes/82/6/en/.
|
| 35. |
Leone P, Fleming DT, Gilsenan AW et al. Seroprevalence of Herpes Simplex Virus-2 in Suburban Primary Care Offices in the United States. Sexually Transmitted Diseases, May 2004; 31(5): 311-316.
|
| 36. |
Swygard H, Sena AC, Hobbs MM and Cohen MS. Trichomoniasis: Clinical Manifestations, Diagnosis and Management. Sex Transm Infect, 2004; 80: 91-95.
|
| 37. |
Cox JT, Petry KU, Rylander E et al. Using Imiquimod for Genital Warts in Female Patients. Journal of Women's Health, 2004; 13(3): 265-271.
|
| 38. |
Mofenson LM. Successes and Challenges in the Perinatal HIV-1 Epidemic in the United States as Illustrated by the HIV-1 Serosurvey of Childbearing Women. Arch Pediatr Adolsc Med, May 2004; 158: 422-425.
|
| 39. |
Cervia JS. The Changing Face of HIV Infection in Children. PRN Notebook, March 2004; 9(1): 20-27. On-line at: www.prn.org.
|
| 40. |
Sedgh G, Spiegelman D, Larsen U et al. Breastfeeding and maternal HIV-1 disease progression and mortality. AIDS, 2004; 18: 1043-1049.
|
| 41. |
Neu N, Leighty R, Adeniyi-Jones S et al. Immune Parameter and Morbidity in Hard Drug and Human Immunodeficiency Virus-Exposed but Uninfected Infants. Pediatrics, May 5, 2004; 113(5): 1260-1266.
|
| 42. |
Divi RL, Walker VE, Wade NA et al. Mitochondrial Damage and DNA Depletion in Cord Blood and Umbilical Cord From Infants Exposed in Utero to Combivir. AIDS, 2004; 18: 1013-1021.
|
Counseling, Testing, and Partner Notification
|
| 43. |
Sullivan PS, Lansky A, Drake A et al. Failure to Return for HIV Test Results Among Persons at High Risk for HIV Infection. J Acquir Immune Defic Syndr, April 15, 2004; 35(5): 511-518.
|
| 44. |
Hutchinson AB, Corbie-Smith G, Thomas SB et al. Understanding the Patient's Perspective on Rapid and Routine HIV Testing in an Inner-City Urgent Care Center. AIDS Education and Prevention, 2004; 16(2): 101-114.
|
| 45. |
Glick NR, Silva A, Zun L et al. HIV Testing in a Resource-Poor Urban Emergency Department. AIDS Education and Prevention, 2004; 16(2): 126-136.
|
| 46. |
Schuman P, Jones TB, Ohmit S et al. Voluntary HIV Counseling and Testing of Pregnant Women—An Assessment of Compliance with Michigan Public Health Statures. Medscape Gen Med, 2004; 6(2): 8 pages. Available on-line at: www.medscape.com.
|
| 47. |
Kates J. HIV Testing in the U.S. (HIV/AIDS Policy Fact Sheet). Kaiser Family Foundation, June 2004. On-line at: www.kff.org.
|
| 48. |
CDC. Voluntary HIV Testing as Part of Routine Medical Care—Massachusetts, 2002. MMWR, June 25, 2004; 53(24): 523-526. On-line at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5324a2.htm.
|
Anti-Retroviral Treatment
|
| 49. |
Brew BJ. Evidence for a change in AIDS Dementia Complex in the Era of Highly Active Antiretroviral Therapy and the Possibility of New Forms of AIDS Dementia Complex. AIDS, 2004; 18(supp 1): S75-S78.
|
| 50. |
Robertson KR, Robertson WT, Ford S et al. Highly Active Anitretroviral Therapy Improves Neurocognitive Functioning. J Acquir Immune Defic Syndr, May 1, 2004; 36(1): 562-566.
|
| 51. |
Smith DE, Walker BD, Cooper DA et al. Is Antiretroviral Treatment of Primary HIV Infection Clinically Justified on the Basis of Current Evidence? AIDS, 2004; 18(5): 709-718.
|
| 52. |
Markowitz M and Walker BD. Update on the Treatment of Acute and Early HIV Infection. PRN Notebook, June 2004; 9(2): 9-14. On-line at: www.prn.org.
|
| 53. |
Stebbing J, Gazzard B, Douek DC et al. Where Does HIV Live? New England Journal of Medicine, April 29, 2004; 350(18): 1872-1880.
|
| 54. |
Mwapasa V, Rogerson SJ, Molyneuz ME et al. The Effect of Plasmodium Falciparum on Peripheral and Placental HIV-1 RNA Concentrations in Pregnant Malawian Women. AIDS, 2004; 18(7): 1051-1059.
|
Racial/Ethnic Disparities
|
| 55. |
Bird ST, Bogart LM and Delahanty DL. Health-Related Correlates of Perceived Discrimination in HIV Care. AIDS Patient Care and STDs, 2004; 18(1): 19-26.
|
| 56. |
Alliance for Health Reform. Closing the Gap: Racial and Ethnic Disparities in Healthcare. Journal of the National Medical Association, April 2004; 96(4): 436-440.
|
| 57. |
Dombrowski JC, Thomas JC and Kaufmann JS. Measures of Racial Disparity in Rates of Sexually Transmitted Disease. Sexually Transmitted Diseases, March 2004; 31(3): 149-153.
|
| |
